We are live on ! Find out more
PSTV icon

Plus Therapeutics

6 hedge funds and large institutions have $1.28M invested in Plus Therapeutics in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 56 (+1)

14% more capital invested

Capital invested by funds: $1.12M → $1.28M (+$160K)

0% less ownership

Funds ownership: 0%0% (-0%)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
1
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$263K
2
VF
Virtu Financial
New York
+$65.7K
Name Holding Trade Value Shares
Change
Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
-$10K

PSTV Hedge Fund Activity: Q1 2018 in Review

6 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2018, worth a combined $1.28M — up 14% from $1.12M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PSTV positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jefferies Group, opening a new position worth an estimated $263K. The largest seller was Jane Street, exiting entirely with an estimated $52K sold.

  • 6 institutional investors held Plus Therapeutics (PSTV) as of Q1 2018, up from 5 in Q4 2017.
  • Funds reported $1.28M of Plus Therapeutics stock for Q1 2018, up 14% quarter-over-quarter.
  • 2 funds opened new Plus Therapeutics positions in Q1 2018 and 1 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q1 2018 was Jefferies Group, an estimated $263K added.
  • The largest Plus Therapeutics seller in Q1 2018 was Jane Street, an estimated $52K sold.

Based on aggregated 13F filings for Q1 2018.